WFDC2 and ovarian carcinoma: To increase the diagnostic power of these parameters, human epididymis protein-4 (HE4), another common used biomarker in the serum of ovarian cancer patients, was used in a newly developed risk of ovarian malignancy algorithm (ROMA) especially to distinguish patients at a low and high risk of EOC [18].